Background. Staphylococcus aureus is a common cause of bacteremia in adults and children. There are published adult guidelines for S. aureus bacteremia management, but there are limited comparative effectiveness data to inform pediatric treatment guidelines.
Describing the clinical characteristics and outcomes of pediatric inpatients with S. aureus bacteremia is necessary to prioritize future comparative effectiveness studies.
Methods. An observational cohort of children >2 months and <19 years was assembled using Premier Perspective TM Database, a nationally representative administrative database of billing and microbiology data. All incident admissions between 2009 and 2012 with lab-confirmed S. aureus bacteremia were included. Outside facility transfer patients were excluded. Admissions with a positive blood culture in the first 3 days were considered community-onset (CO); those beyond 3 days were considered healthcare-onset (HO). Two infectious diseases physicians independently reviewed all ICD-9 codes per admission to determine the source of bacteremia; subsequent reviewer discussion adjudicated disagreements. Wilcoxon rank-sum and Chi squared tests were used to compare medians and proportions, respectively.
Results. There were 414 patients with S. aureus bacteremia; median age was 6.5 years (IQR: 1 to 13 years). Patients were more frequently white (n = 218, 53%), male (n = 261, 63%) and had CO infection (n= 368, 89%). Length of stay (LOS) after onset of bacteremia was longer for patients with HO (HO: 14 days, IQR: 5 to 28 vs CO: 5 days, IQR: 3 to 9; p <0.001). The source of bacteremia was determined in 346 patients (84%) and was most commonly a bone/joint (HO: n = 14, 30%; CO: n = 140, 38%), skin/soft tissue (HO: n = 8, 17%; CO: n = 71, 19%), or pneumonia (HO: n = 5, 11%; CO: n = 40, 11%). The HO case fatality rate was higher than for CO (11% vs 2%, p = 0.0038).
Conclusion. This is the first large, multi-center study of pediatric S. aureus bacteremia. CO bacteremia was more common, but HO bacteremia patients had longer LOS and higher case fatality rates. Future analyses will explore the impact of treatment strategies on patient outcomes.
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